MDXG
MiMedx Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+3.16%Margins
Gross margin
78.8%
EBITDA margin
6.7%
EBIT margin
2.5%
Net margin
1.8%
FCF margin
11.4%
2.9%
Return on equity
2.2%
Return on assets
4.0%
Return on invested capital
1.20x
Asset turnover
$46.1M
Cash from operations
$0.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026